EPIGENOMICS AG (ECX.DE) Forecast, Price Target & Analyst Ratings
FRA:ECX • DE000A37FT41
0.7 EUR
-0.09 (-11.17%)
Last: Jun 27, 2024, 07:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EPIGENOMICS AG (ECX.DE).
Forecast Snapshot
Consensus Price Target
€16.32
+ 2,231.43% Upside
Next Earnings Forecast
Release DateSep 30, 2024
ChartMill Buy Consensus
80.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
€16.32
Upside
+ 2,231.43%
From current price of €0.70 to mean target of €16.32, Based on 6 analyst forecasts
Low
€16.16
Median
€16.32
High
€16.80
Price Target Revisions
1 Month
0.00%
3 Months
-5.60%
Price Target Summary
6 Wall Street analysts provided a forecast for the next 12 months for ECX.DE. The average price target is 16.32 EUR. This implies a price increase of 2231.43% is expected in the next year compared to the current price of 0.7.
The average price target has been revised downward by 5.6% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
ECX.DE was analyzed by 6 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about ECX.DE.
In the previous month the buy percentage consensus was at a similar level.
ECX.DE was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
Release DateSep 30, 2024
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 842K -25.16% | 6.203M 636.70% | 485K -92.18% | 16.944M 3,393.61% | 303K -98.21% | -100.00% | 4.205M | 29.532M 602.31% | 44.298M 50.00% | 59.064M 33.33% | 68.94M 16.72% | |
| EBITDA YoY % growth | -9.579M 34.34% | -3.743M 60.92% | -12.11M -223.54% | -5.656M 53.29% | -1.01M 82.14% | 100.00% | -14.46M | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -10.114M 33.03% | -4.162M 58.85% | -12.859M -208.96% | -3.204M 75.09% | -1.01M 68.47% | -1.01M | -2.445M -142.05% | 5.574M 328.00% | 9.388M 68.42% | 13.201M 40.62% | 15.353M 16.30% | |
| Operating Margin | -1,201.19% | -67.10% | -2,651.34% | -18.91% | -333.33% | N/A | -58.14% | 18.87% | 21.19% | 22.35% | 22.27% | |
| EPS YoY % growth | N/A 44.54% | N/A 68.67% | N/A -20.00% | -7.28 47.75% | -0.90 87.66% | -0.58 35.96% | -0.86 -49.63% | N/A | N/A | N/A | N/A |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
25.12%
EPS Next 5 Year
17.99%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
-25.99%
Revenue Next 5 Year
108.06%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
25.99%
EBIT Next 5 Year
-7.05%
EPIGENOMICS AG / ECX.DE Forecast FAQ
What is the average price target for EPIGENOMICS AG (ECX.DE) stock?
6 analysts have analysed ECX.DE and the average price target is 16.32 EUR. This implies a price increase of 2231.43% is expected in the next year compared to the current price of 0.7.
What is the next earnings date for ECX stock?
EPIGENOMICS AG (ECX.DE) will report earnings on 2024-09-30.
What is the consensus rating for EPIGENOMICS AG (ECX.DE) stock?
The consensus rating for EPIGENOMICS AG (ECX.DE) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.